menu search
Trades24h logo
 Register
close Tap here to search
  1. Home

  2. News

  3. Stock Details

Subscribe To  

  Price Alert   Latest News   Economic Calendar News

DNAY / Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022

Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced details for its first Investor R&D Webinar. Management will describe the future promise of the company's R&D pipeline, with a specific focus on its proprietary Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis technology. Read More
Hmarkets Logo
Demo chevron_right Live Account chevron_right See Partner Details

Content Topics

Codex

Announces

Registration

Webcast

Information

Upcoming

Webinar

Stock

DNAY

Posted: Mar 3 2022, 08:03
Author Name: GlobeNewsWire
Views: 111548

DNAY News  

Codex DNA to Present at the 2022 Jefferies Healthcare Conference

By GlobeNewsWire
June 2, 2022

Codex DNA to Present at the 2022 Jefferies Healthcare Conference

SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announce more_horizontal

Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 14, 2022

Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q1 2022 Results - Earnings Call Transcript

Codex DNA, Inc. (NASDAQ:DNAY ) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Richard Lepke - Director, Investor Relati more_horizontal

Codex DNA to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022

By GlobeNewsWire
May 3, 2022

Codex DNA to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022

SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced more_horizontal

Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 22, 2022

Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q4 2021 Results - Earnings Call Transcript

Codex DNA, Inc. (DNAY) CEO Todd Nelson on Q4 2021 Results - Earnings Call Transcript more_horizontal

Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022

By GlobeNewsWire
March 3, 2022

Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022

SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announc more_horizontal

Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022

By GlobeNewsWire
March 3, 2022

Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022

SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announc more_horizontal

Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022

By GlobeNewsWire
March 3, 2022

Codex DNA Announces Registration and Webcast Information for Upcoming R&D Webinar on March 29, 2022

SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announc more_horizontal

Codex DNA to Report Fourth Quarter 2021 Financial Results on Tuesday, March 22, 2022

By GlobeNewsWire
March 2, 2022

Codex DNA to Report Fourth Quarter 2021 Financial Results on Tuesday, March 22, 2022

SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announc more_horizontal

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

©2014-2024 All Rights Reserved. I.C

Hand-crafted & made with Love

logo close

Search within

Pages Search Results: